AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India

• Main Authors: Harbans Singh (Author), Sumit Srivastava (Author), Babita Yadav (Author), Amit K. Rai (Author), Sophia Jameela (Author), Sanuj Muralidharan (Author), Rijin Mohan (Author), Shikha Chaudhary (Author), Richa Singhal (Author), Rakesh Rana (Author), Shruti Khanduri (Author), Bhagwan S. Sharma (Author), Bhogavalli Chandrasekhararao (Author), Narayanam Srikanth (Author), Sarika Chaturvedi (Author)
• Format: Book
• Published: Elsevier, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To determine the therapeutic efficacy and safety of AYUSH-64 as an add-on to standard care in mild to moderate COVID-19. Design setting, and interventions: This open-label randomized controlled parallel-group trial was conducted at a designated COVID care centre in India in 80 patients di...